Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Innate Pharma cleared to begin phase II study of IPH-2102 in AML

Sep. 4, 2012

Lorus Therapeutics receives funding to support development of IL-17E

Sep. 4, 2012

VLST licenses CP-870893 from Pfizer

Sep. 3, 2012

Lead Nordic Nanovector product clear to enter clinic

Aug. 31, 2012

Genmab and Janssen Biotech form worldwide agreement

Aug. 31, 2012

Genmab designs novel CD74-directed immunotherapies

Aug. 29, 2012

TG Therapeutics highlights potential of ublituximab for new indication

Aug. 28, 2012

Updated results from EMILIA study of trastuzumab emtansine

Aug. 27, 2012

Northwest Bio gains MHRA clearance for DCVax-L trial

Aug. 24, 2012

NICE publishes draft guidance on denosumab

Aug. 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 22, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.